High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience.
Spinolo
J A
JA
M. D. Anderson Cancer Center, University of Texas, Houston 77030.
Jagannath
S
S
Dicke
K A
KA
Smith
K E
KE
Cabanillas
F
F
Hagemeister
F B
FB
Horwitz
L J
LJ
McLaughlin
P
P
Swan
F
F
Spitzer
G
G
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002330:Carmustine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D005047:Etoposide; D003520:Cyclophosphamide; D002330:Carmustine